434
Views
29
CrossRef citations to date
0
Altmetric
Review Article

Perfluorocarbon liquids in vitreoretinal surgery: a review of applications and toxicity

, , , , , & show all
Pages 251-262 | Received 02 Nov 2010, Accepted 26 Jan 2011, Published online: 08 Nov 2011

References

  • Chang S, Zimmerman NJ, Iwamoto T, Ortiz R, Faris D. Experimental vitreous replacement with perfluorotributylamine. Am J Ophthalmol 1987;103:29–37.
  • Chang S. Low viscosity liquid fluorochemicals in vitreous surgery. Am J Ophthalmol 1987;103:38–43.
  • Berrocal MH, Chang S. Perfluorocarbon liquids in vitreous surgery. Ophthalmol Clin N Am 1994;7:67–76.
  • Velikay M, Wedrich A, Stolba U, Datlinger P, Li Y, Binder S. Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin. Am J Ophthalmol 1993;116:565–570.
  • Devin F, Jourdan T, Saracco JB, Lucciani A. Experimental tolerance to perfluorodecalin used in prolonged intraocular tamponade. Ophthalmologica 1995;209:306–314.
  • Eckardt C, Nicolai U, Winter M, Knop E. Experimental intraocular tolerance to liquid perfluorooctane and perfluoropolyether. Retina (Philadelphia, Pa) 1991;11:375–384.
  • Nabih M, Peyman GA, Clark LC Jr, Hoffman RE, Miceli M, Abou-Steit M et al. Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report. Ophthalmic Surg 1989;20:286–293.
  • Banker AS, Freeman WR, Vander JF, Flores-Aguilar M, Munguia D. Use of perflubron as a new temporary vitreous substitute and manipulation agent for vitreoretinal surgery. Retina 1996;16:285–291.
  • Bottoni F, Sborgia M, Arpa P, De Casa N, Bertazzi E, Monticelli M et al. Perfluorocarbon liquids as postoperative short-term vitreous substitutes in complicated retinal detachment. Graefes Arch Clin Exp Ophthalmol 1993;231:619–628.
  • Conway MD, Peyman GA, Karaçorlu M, Bhatt N, Soike KF, Clark LC Jr et al. Perfluorooctylbromide (PFOB) as a vitreous substitute in non-human primates. Int Ophthalmol 1993;17:259–264.
  • Sargent JW, Seffl RJ. Properties of perfluorinated liquids. Fed Proc 1970;29:1699–1703.
  • Sparrow JR, Jayakumar A, Berrocal M, Ozmert E, Chang S. Experimental studies of the combined use of vitreous substitutes of high and low specific gravity. Retina (Philadelphia, Pa) 1992;12:134–140.
  • Lavin M. Heavy liquids for postoperative tamponade. Br J Ophthalmol 1992;76:513–514.
  • Bourke RD. Perfluorocarbon heavy liquids. Eye (Lond) 1995;9:v–vii.
  • Bourke RD, Cooling RJ. Perfluorocarbon heavy liquids. Aust N Z J Ophthalmol 1995;23:165–171.
  • Bacon AS, Lavin MJ. Perfluorocarbon liquids: potential interaction during vitreoretinal surgery. Poster, annual meeting of the college of Ophthalmologists of UK, Glasgow, 1991.
  • Blinder KJ, Peyman GA, Desai UR, Nelson NC Jr, Alturki W, Paris CL. Vitreon, a short-term vitreoretinal tamponade. Br J Ophthalmol 1992;76:525–528.
  • Benchekroun O, Lahbil D, Rachid R, Laaouissi N, Zaghloul K, AmraouiL A. Les perfluorocarbones liquids dans la chirurgie vitreoretinienne. J Fr. Ophthalmol 1998;21:773–781.
  • Kobuch K, Menz IH, Hoerauf H, Dresp JH, Gabel VP. New substances for intraocular tamponades: perfluorocarbon liquids, hydrofluorocarbon liquids and hydrofluorocarbon-oligomers in vitreoretinal surgery. Graefes Arch Clin Exp Ophthalmol 2001;239:635–642.
  • Mathis A, Pagot V, Gazagne C, Malecaze F. Giant retinal tears. Surgical techniques and results using perfluorodecalin and silicone oil tamponade. Retina (Philadelphia, Pa) 1992;12:S7–10.
  • Chauvaud D. Decollement de retine par dechirure geante. Vision Int 1997;72:24–28.
  • Larricart P, Le Mer Y, Petit E, Flamand M, Haut J. [Liquid perfluorocarbons in the surgical treatment of retinal detachment caused by retinal inversion]. J Fr Ophtalmol 1993;16:673–678.
  • Ambresin A, Wolfensberger TJ, Bovey EH. Management of giant retinal tears with vitrectomy, internal tamponade, and peripheral 360 degrees retinal photocoagulation. Retina (Philadelphia, Pa) 2003;23:622–628.
  • Peyman GA, Schulman JA, Sullivan B. Perfluorocarbon liquids in ophthalmology. Surv Ophthalmol 1995;39:375–395.
  • Greve MD, Peyman GA, Millsap CM. Relaxing retinotomy under perfluorocarbon liquid. Ophthalmic Surg Lasers 1996;27:154–155.
  • Romano MR, Baddon C, Heimann H, Wong D, Hiscott P. Histopathological findings in an epimacular membrane after intraoperative use of perfluorocarbon liquid. Eye (Lond) 2010;24:740–742.
  • Stolba U, Binder S, Velikay M, Datlinger P, Wedrich A. Use of perfluorocarbon liquids in proliferative vitreoretinopathy: results and complications. Br J Ophthalmol 1995;79:1106–1110.
  • Carroll BF, Peyman GA, Mehta NJ, Millsap CM, Greve MD, Dunlap WA et al. Repair of retinal detachment associated with proliferative vitreoretinopathy using perfluoroperhydrophenanthrene (Vitreon). Vitreon Study Group. Can J Ophthalmol 1994;29:66–69.
  • Coll GE, Chang S, Sun J, Wieland MR, Berrocal MH. Perfluorocarbon liquid in the management of retinal detachment with proliferative vitreoretinopathy. Ophthalmology 1995;102:630–8; discussion 638.
  • Kapran Z, Uyar OM, Kaya V, Eltutar K. Recurrences of retinal detachment after vitreoretinal surgery, and surgical approach. Eur J Ophthalmol 2001;11:166–170.
  • Chang S, Lincoff H, Zimmerman NJ, Fuchs W. Giant retinal tears. Surgical techniques and results using perfluorocarbon liquids. Arch Ophthalmol 1989;107:761–766.
  • Le Mer Y, Haut J. [Use of perfluoro-octane liquid in the treatment of giant tears with inversion of the retina: preliminary results]. J Fr Ophtalmol 1990;13:247–251.
  • López-Guajardo L, Benitez-Herreros J, Dapena I. Simple maneuver for unfolding giant retinal tear inverted flap trapped under perfluorocarbon bubble. Ophthalmic Surg Lasers Imaging 2010;41:394–396.
  • Kertes PJ, Wafapoor H, Peyman GA, Calixto N Jr, Thompson H. The management of giant retinal tears using perfluoroperhydrophenanthrene. A multicenter case series. Vitreon Collaborative Study Group. Ophthalmology 1997;104:1159–1165.
  • Zhioua R, Malek I, Kria L, Ouertani A. [Retinal detachment associated with giant retinal tear: surgical procedures and results of the perfluorocarbon liquid-silicone oil exchange with scleral buckling]. J Fr Ophtalmol 2005;28:366–370.
  • Rofail M, Lee LR. Perfluoro-n-octane as a postoperative vitreoretinal tamponade in the management of giant retinal tears. Retina (Philadelphia, Pa) 2005;25:897–901.
  • Scott IU, Murray TG, Flynn HW Jr, Feuer WJ, Schiffman JC; Perfluoron Study Group. Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology 2002;109:1828–1833.
  • Chang S, Reppucci V, Zimmerman NJ, Heinemann MH, Coleman DJ. Perfluorocarbon liquids in the management of traumatic retinal detachments. Ophthalmology 1989;96:785–91; discussion 791.
  • Chang S. Perfluorocarbon liquids in vitreoretinal surgery. Int Ophthalmol Clin 1992;32:153–163.
  • Desai UR, Peyman GA, Harper CA 3rd. Perfluorocarbon liquid in traumatic vitreous hemorrhage and retinal detachment. Ophthalmic Surg 1993;24:537–541.
  • Soheilian M, Peyman GA, Wafapoor H, Navarro GC, Thompson H. Surgical management of traumatic retinal detachment with perfluorocarbon liquid. The Vitreon Study Group. Int Ophthalmol 1996;20:241–249.
  • Movshovich A, Berrocal M, Chang S. The protective properties of liquid perfluorocarbons in phacofragmentation of dislocated lenses Retina. 1994;14:457–462.
  • Nacef L, Daghfous F, Bouguila H, Baccar M, Ayed S. [Retinal detachment and posterior lens luxation. Value of liquid perfluorocarbons]. J Fr Ophtalmol 1996;19:432–434.
  • Greve MD, Peyman GA, Mehta NJ, Millsap CM. Use of perfluoroperhydrophenanthrene in the management of posteriorly dislocated crystalline and intraocular lenses. Ophthalmic Surg 1993;24:593–597.
  • Verma L, Gogoi M, Tewari HK, Kumar A, Talwar D. Comparative study of vitrectomy for dropped nucleus with and without the use of perfluorocarbon liquid. Clinical, electrophysiological and visual field outcomes. Acta Ophthalmol Scand 2001;79:354–358.
  • Le Mer Y. [Use of liquid perfluorocarbons in vitrectomy for difficult cases of proliferative diabetic retinopathy]. J Fr Ophtalmol 1995;18:366–372.
  • Yadarola MB, Gramajo AL, Arrambide MP, Colombres GA, Juarez CP, Luna JD. Perfluorocarbon liquid vitreous delamination and wide-angle viewing system in the management of complicated diabetic retinal detachment. Eur J Ophthalmol 2009;19:452–459.
  • Brazitikos PD, D’Amico DJ, Tsinopoulos IT, Stangos NT. Primary vitrectomy with perfluoro-n-octane use in the treatment of pseudophakic retinal detachment with undetected retinal breaks. Retina (Philadelphia, Pa) 1999;19:103–109.
  • Lee SC, Lee I, Koh HJ, Kim SH, Kwon OW. Massive suprachoroidal hemorrhage with retinal and vitreous incarceration; a vitreoretinal surgical approach. Korean J Ophthalmol 2000;14:41–44.
  • Desai UR, Peyman GA, Chen CJ, Nelson NC Jr, Alturki WA, Blinder KJ et al. Use of perfluoroperhydrophenanthrene in the management of suprachoroidal hemorrhages. Ophthalmology 1992;99:1542–1547.
  • Kamei M, Tano Y, Maeno T, Ikuno Y, Mitsuda H, Yuasa T. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996;121:267–275.
  • Jonas JB, Jager M. Perfluorohexyloctane endotamponade for treatment of subfoveal hemorrhage. Eur J Ophthalmol 2002;12:534–536.
  • Millsap CM, Peyman GA, Ma PE, Greve MD. The surgical management of retinopathy of prematurity using a perfluorocarbon liquid. Int Ophthalmol 1994;18:97–100.
  • Devenyi RG. The use of perfluorocarbon liquid in the surgical repair of stage 5 retinopathy of prematurity. Can J Ophthalmol 1993;28:294–295.
  • Lomeo MD, Diaz-Rohena R, Lambert HM. Use of perfluorocarbon liquid in the repair of retinoschisis retinal detachments. Ophthalmic Surg Lasers 1996;27:778–781.
  • Aslan O, Batman C, Cekic O, Ozalp S. The use of perfluorodecalin in retinal detachments with retinoschisis. Ophthalmic Surg Lasers 1998;29:818–821.
  • Nishimura A, Kita K, Segawa Y, Shirao Y. Perfluorocarbon liquid assists in stripping the ILM to treat detached retina caused by macular hole. Ophthalmic Surg Lasers 2002;33:77–78.
  • Scupola A, Giammaria D, Tiberti AC, Balestrazzi E. Use of perfluorocarbon liquid to prevent contact between indocyanine green and retinal pigment epithelium during surgery for idiopathic macular hole. Retina (Philadelphia, Pa) 2006;26:236–237.
  • Duker JS, Schuman JS. Successful surgical treatment of hypotony maculopathy following trabeculectomy with topical mitomycin C. Ophthalmic Surg 1994;25:463–465.
  • Kertes PJ, Peyman GA. Management of dry retinal folds. Int Ophthalmol 1997;21:53–55.
  • Forlini C, Del Fiume E, Cicognani A, D’Eliseo D. Use of PFCL in the surgical management of endophthalmitis: New indications. J Vitreo Retina 1992;1:55–63.
  • Peyman GA, Schulman JA. Intravitreal Surgery. Principles and Practice. Norwalk, CT, Appleton- Century- Crofts 1986; 384.
  • Gopal L, Kini MM, Badrinath SS, Sharma T. Management of retinal detachment with choroidal coloboma. Ophthalmology 1991;98:1622–1627.
  • Lee KJ, Peyman GA, Paris CL, Alturki WA, Desai UR. Management of retinal detachment associated with choroidal coloboma using perfluoroperhydrophenanthrene (Vitreon). Ophthalmic Surg 1992;23:553–554.
  • Lambert HM, Capone A Jr, Aaberg TM. Surgical excision of subfoveal neovascular membranes in age-related macular degeneration. Am J Ophthalmol 1992;113:257–262.
  • Lesnoni G, Rossi T, Gelso A. Subfoveal liquid perfluorocarbon. Retina (Philadelphia, Pa) 2004;24:172–176.
  • Sakurai E, Ogura Y. Removal of residual subfoveal perfluoro-n-octane liquid. Graefes Arch Clin Exp Ophthalmol 2007;245:1063–1064.
  • Osterholz. J, Winter M, Winkler J, Pfister G, Kovacs G, Dresp J, Menz D-H, Hoerauf H. Retinal damage by perfluorocarbon liquids - a question of specific gravity? Intraocular pressure peaks and shearing forces klin monatsbl augenheilkd 2009;226:38–47.
  • Mackiewicz J, Maaijwee K, Lüke C, Kociok N, Hiebl W, Meinert H et al. Effect of gravity in long-term vitreous tamponade: in vivo investigation using perfluorocarbon liquids and semi-fluorinated alkanes. Graefes Arch Clin Exp Ophthalmol 2007;245:665–675.
  • Chang S, Sparrow JR, Iwamoto T, Gershbein A, Ross R, Ortiz R. Experimental studies of tolerance to intravitreal perfluoro-n-octane liquid. Retina (Philadelphia, Pa) 1991;11:367–374.
  • Zeana D, Becker J, Kuckelkorn R, Kirchhof B. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution. Int Ophthalmol 1999;23:17–24.
  • Berglin L, Ren J, Algvere PV. Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes. Graefes Arch Clin Exp Ophthalmol 1993;231:233–237.
  • Matteucci A, Formisano G, Paradisi S, Carnovale-Scalzo G, Scorcia G, Caiazza S et al. Biocompatibility assessment of liquid artificial vitreous replacements: relevance of in vitro studies. Surv Ophthalmol 2007;52:289–299.
  • Sparrow JR, Ortiz R, MacLeish PR, Chang S. Fibroblast behavior at aqueous interfaces with perfluorocarbon, silicone, and fluorosilicone liquids. Invest Ophthalmol Vis Sci 1990;31:638–646.
  • Inoue M, Iriyama A, Kadonosono K, Tamaki Y, Yanagi Y. Effects of perfluorocarbon liquids and silicone oil on human retinal pigment epithelial cells and retinal ganglion cells. Retina. 2009;29:677–681.
  • Stolba U, Krepler K, Velikay-Parel M, Binder S. The effect of specific gravity of perfluorocarbon liquid on the retina after experimental vitreous substitution. Graefes Arch Clin Exp Ophthalmol 2004;242:931–936.
  • Elsing SH, Fekrat S, Green WR, Chang S, Wajer SD, Haller JA. Clinicopathologic findings in eyes with retained perfluoro-n-octane liquid. Ophthalmology 2001;108:45–48.
  • Drury B, Bourke RD. Short-term intraocular tamponade with perfluorocarbon heavy liquid. Br J Ophthalmol 2010 (In Press).
  • Singh J, Ramaesh K, Wharton SB, Cormack G, Chawla HB. Perfluorodecalin-induced intravitreal inflammation. Retina (Philadelphia, Pa) 2001;21:247–251.
  • Lai JC, Postel EA, McCuen BW 2nd. Recovery of visual function after removal of chronic subfoveal perfluorocarbon liquid. Retina (Philadelphia, Pa) 2003;23:868–870.
  • Cohen SY, Dubois L, Elmaleh C. Retinal hole as a complication of long-standing subretinal perfluorocarbon liquid. Retina (Philadelphia, Pa) 2006;26:843–844.
  • Garcia-Valenzuela E, Ito Y, Abrams GW. Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery. Retina (Philadelphia, Pa) 2004;24:746–752.
  • Giuliari GP, Cortez MA, Ubiera J. Perfluorocarbon liquid left in vitreous cavity after recovery of dropped nuclei by anterior segment surgeons after cataract surgery. Can J Ophthalmol 2007;42:617–619.
  • Feitosa de Souza C, Calonge Cano M, Pastor Jimeno JC, Baílez Fidalgo C, Saornil Alvarez MA, Méndez Díaz MC. Sympathetic ophthalmia post-vitrectomy following trauma and perfluorocarbon liquid tamponade. Arch Soc Esp Oftalmol 2004;79:553–556.
  • Verma LK, Peyman GA, Wafapoor H, Greve MD, Millsap CM, Adile SL. An analysis of posterior segment complications after vitrectomy using the perfluorocarbon perfluoroperhydrophenanthrene (Vitreon). Vitreon Collaborative Study. Ophthalmic Surg 1995;26:29–33.
  • Moreira H, de Queiroz JM Jr, Liggett PE, McDonnell PJ. Corneal toxicity study of two perfluorocarbon liquids in rabbit eyes. Cornea 1992;11:376–379.
  • Ramaesh K, Bhagat S, Wharton SB, Singh J. Corneal epithelial toxic effects and inflammatory response to perfluorocarbon liquid. Arch Ophthalmol 1999;117:1411–1413.
  • Weinberger D, Goldenberg-Cohen N, Axer-Siegel R, Gaton DD, Yassur Y. Long-term follow-up of perfluorocarbon liquid in the anterior chamber. Retina (Philadelphia, Pa) 1998;18:233–237.
  • Aydin E, Demir HD. Perfluorodecaline residue in the anterior chamber of a patient with an intact crystalline lens: a case report. J Med Case Reports 2008;2:13.
  • Wilbanks GA, Apel AJ, Jolly SS, Devenyi RG, Rootman DS. Perfluorodecalin corneal toxicity: five case reports. Cornea 1996;15:329–334.
  • Cauchi P, Azuara-Blanco A, McKenzie J. Corneal toxicity and inflammation secondary to retained perfluorodecalin. Am J Ophthalmol 2005;140:322–323.
  • Alster Y, Ben-Nun Y, Loewenstein A, Lazar M. Pupillary block glaucoma due to residual perfluoro-decalin. Ophthalmic Surg Lasers 1996;27:395–396.
  • Wagenfeld L, Zeitz O, Skevas C, Richard G. Long-lasting endotamponades in vitreoretinal surgery. Ophthalmologica 2010;224:291–300.
  • Vote B, Wheen L, Cluroe A, Teoh H, McGeorge A. Further evidence for proinflammatory nature of perfluorohexyloctane in the eye. Clin Experiment Ophthalmol 2003;31:408–414.
  • Gerding H, Kolck A. [Perfluorohexyloctane as internal tamponade in patients with complicated retinal detachment. Results after 6 months]. Ophthalmologe 2004;101:255–262.
  • Herbert EN, Groenewald C, Wong D. Treatment of retinal folds using a modified macula relocation technique with perfluoro-hexyloctane tamponade. Br J Ophthalmol 2003;87:921–922.
  • Jonas JB, Jäger M. Perfluorohexyloctane endotamponade for treatment of persisting macular hole. Eur J Ophthalmol 2003;13:103–104.
  • Kirchhof B, Wong D, Van Meurs J, Hilgers RD, Macek M, Lois N et al. Use of perfluorohexyloctane as a long-term internal tamponade agent in complicated retinal detachment surgery. Am J Ophthalmol 2002;133:95–101.
  • Ding X, Li C, Lu L, Feng G, Zheng H. Experiment study of effect of perfluorohexyloctane on corneal endothelial cells. Yan Ke Xue Bao 2001;17:21–26.
  • Martinez-Reina MJ, Ruiz-Moreno JM, Montero JA, Rueda J. Histopathology and ultrastructure of rabbit retina after intravitreous injection of perfluorohexyloctane (F6H8). Curr Eye Res 2005;30:773–779.
  • Sorcinelli R, Lai ML. Unusual complication after temporary use of perfluorohexyloctane (f6h8) in the treatment of complicated retinal detachment. Retina (Philadelphia, Pa) 2005;25:89–90.
  • Schatz B, El-Shabrawi Y, Haas A, Langmann G. Adverse side effects with perfluorohexyloctane as a long-term tamponade agent in complicated vitreoretinal surgery. Retina (Philadelphia, Pa) 2004;24:567–573.
  • Rizzo S, Genovesi-Ebert F, Belting C. The combined use of perfluorohexyloctane (F6H8) and silicone oil as an intraocular tamponade in the treatment of severe retinal detachment. Graefes Arch Clin Exp Ophthalmol 2006;244:709–716.
  • Tognetto D, Lepori L, Lapasin R, Minutola D, Sanguinetti G, Michelone L et al. A new heavy internal tamponade in vitreoretinal surgery: an in vitro study. Eye (Lond) 2008;22:1082–1088.
  • Wong D, Van Meurs JC, Stappler T, Groenewald C, Pearce IA, McGalliard JN et al. A pilot study on the use of a perfluorohexyloctane/silicone oil solution as a heavier than water internal tamponade agent. Br J Ophthalmol 2005;89:662–665.
  • Quiroz-Mercado H, Garcia-Aguirre G, Ustáriz-González O, Martín-Avià J, Martinez-Jardon S. Perfluorocarbon-perfused vitrectomy using a transconjunctival 25-gauge system. Retina (Philadelphia, Pa) 2007;27:926–931.
  • Quiroz-Mercado H, Suarez-Tatá L, Magdalenic R, Murillo-López S, García-Aguirre G, Guerrero-Naranjo J et al. Perfluorocarbon perfused vitrectomy: animal studies. Am J Ophthalmol 2004;137:287–293.
  • Quiroz-Mercado H, Guerrero-Naranjo J, Agurto-Rivera R, Leizaola-Fernández C, Suárez-Tatá L, Murillo-López S et al. Perfluorocarbon-perfused vitrectomy: a new method for vitrectomy–a safety and feasibility study. Graefes Arch Clin Exp Ophthalmol 2005;243:551–562.
  • Quiroz-Mercado H, Rivera-Sempertegui J, Macky TA, Navarro-López P, Griselda-Alvarez L, Ibarra-Ponce N et al. Performing vitreous biopsy by perfluorocarbon-perfused vitrectomy. Am J Ophthalmol 2005;140:1161–1163.
  • Arevalo JF. En bloc perfluorodissection in vitreoretinal surgery: a new surgical technique. Retina (Philadelphia, Pa) 2008;28:653–656.
  • Arevalo JF. En bloc perfluorodissection for tractional retinal detachment in proliferative diabetic retinopathy. Ophthalmology 2008;115:e21–e25.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.